Bausch Health Cos Investing Activities - Other 2010-2025 | BHC
Bausch Health Cos investing activities - other from 2010 to 2025. Investing activities - other can be defined as the net amount of items a company reports that are too small to report separately. Additionally, this field holds the sum of items a company reports that cannot be assigned to any other standardized field in the investing activities section of the Cash Flows Statement
Bausch Health Cos Annual Investing Activities - Other
(Millions of US $) |
| 2024 |
$13 |
| 2023 |
$13 |
| 2022 |
$N/A |
| 2021 |
$27 |
| 2020 |
$23 |
| 2019 |
$N/A |
| 2018 |
$N/A |
| 2017 |
$-25 |
| 2016 |
$-30 |
| 2015 |
$153 |
| 2014 |
$N/A |
| 2013 |
$N/A |
| 2012 |
$-9 |
| 2011 |
$N/A |
| 2010 |
$-2 |
| 2009 |
$1 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$1.623B |
$9.625B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
